<div class="content-intro"><p>Ready to revolutionize healthcare, making it faster and more accessible than ever before? </p> <p><span style="font-size: 14pt;"><strong>How we started:</strong></span></p> <p>Founded in 2013 by Dwayne D’Souza, HeliosX<em> </em>was built on a simple but powerful idea: healthcare should be easier to access, faster to receive, and centred around the individual.
From day one, we’ve grown without external funding; scaling profitably through technology, disciplined execution, and deep medical expertise.
What started as a challenger idea has become one of the most significant healthcare platforms operating globally today.
</p> <p><span style="font-size: 14pt;"><strong>Where we are now:</strong></span></p> <p>We’ve earned the trust of millions of people worldwide through category-leading products and well-known brands, including MedExpress, Dermatica, ZipHealth, RocketRX, and Levity.
A key driver of our success is vertical integration; we operate our own manufacturing and proprietary products, led by in-house medical teams, researchers, and pharmacists at the top of their fields.
</p> <p>In 2025, HeliosX treated more than 1.
7 million patients globally and reached £781m in revenue, representing +337% year-on-year growth and cementing our position as the clear market leader in the UK.
That growth translates into real-world outcomes: our weight-loss treatments helped patients lose 8.
5 million kilograms of excess weight in 2025 alone, contributing to an estimated 1,300 fewer cardiac events.
This is growth with measurable, life-changing impact at scale.
</p> <p>Today, we operate across four international markets, with successful launches in Germany and Canada and continued expansion in the US.
We were also recently recognised in the Sunday Times Top 100 fastest-growing tech companies, further validation of both our momentum and our ambition.
</p> <p><span style="font-size: 14pt;"><strong>Where we’re going:</strong></span></p> <p>2026.